CD22 and Siglec-G in B cell function and tolerance

Goodnow, 1989, Induction of self-tolerance in mature peripheral B lymphocytes, Nature, 342, 385, 10.1038/342385a0 Klinman, 1996, The “clonal selection hypothesis” and current concepts of B cell tolerance, Immunity, 5, 189, 10.1016/S1074-7613(00)80314-3 Merrell, 2006, Identification of anergic B cells within a wild-type repertoire, Immunity, 25, 953, 10.1016/j.immuni.2006.10.017 Gauld, 2005, Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling, Nat. Immunol., 6, 1160, 10.1038/ni1256 Goodnow, 1988, Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice, Nature, 334, 676, 10.1038/334676a0 O’Neill, 2009, Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells, Proc. Natl. Acad. Sci. U.S.A., 106, 6262, 10.1073/pnas.0812922106 Smith, 2010, B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals, Int. Immunol., 22, 681, 10.1093/intimm/dxq055 Stadanlick, 2008, BAFF and the plasticity of peripheral B cell tolerance, Curr. Opin. Immunol., 20, 158, 10.1016/j.coi.2008.03.015 Poe, 2004, CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms, Nat. Immunol., 5, 1078, 10.1038/ni1121 Poe, 2004, Severely-impaired B lymphocyte proliferation, survival and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background, J. Immunol., 172, 2100, 10.4049/jimmunol.172.4.2100 Poe, 2011, Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice, PLoS ONE, 6, e22464, 10.1371/journal.pone.0022464 DiLillo, 2010, B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer, Ann. N. Y. Acad. Sci., 1183, 38, 10.1111/j.1749-6632.2009.05137.x Dintzis, 1989, The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence, J. Immunol., 143, 1239, 10.4049/jimmunol.143.4.1239 Mond, 1995, T cell-independent antigens type 2, Annu. Rev. Immunol., 13, 655, 10.1146/annurev.iy.13.040195.003255 Perlmutter, 1978, Subclass restriction of murine anti-carbohydrate antibodies, J. Immunol., 121, 566, 10.4049/jimmunol.121.2.566 Haas, 2002, Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses, Immunity, 17, 713, 10.1016/S1074-7613(02)00483-1 Haas, 2005, B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae, Immunity, 23, 7, 10.1016/j.immuni.2005.04.011 Martin, 2001, Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens, Immunity, 14, 617, 10.1016/S1074-7613(01)00129-7 Fagarasan, 2000, T-Independent immune response: new aspects of B cell biology, Science, 290, 89, 10.1126/science.290.5489.89 Martin, 2002, Marginal-zone B cells, Nat. Rev. Immunol., 2, 323, 10.1038/nri799 Maseda, 2012, Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo, J. Immunol., 188, 1036, 10.4049/jimmunol.1102500 Yanaba, 2009, The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals, J. Immunol., 182, 7459, 10.4049/jimmunol.0900270 Crocker, 2007, Siglecs and their roles in the immune system, Nat. Rev. Immunol., 7, 255, 10.1038/nri2056 Tedder, 1997, CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling, Annu. Rev. Immunol., 15, 481, 10.1146/annurev.immunol.15.1.481 Hoffmann, 2007, Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population, Nat. Immunol., 8, 695, 10.1038/ni1480 Jellusova, 2010, Siglec-G regulates B1 cell survival and selection, J. Immunol., 185, 3277, 10.4049/jimmunol.1001792 Nitschke, 2009, CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions, Immunol. Rev., 230, 128, 10.1111/j.1600-065X.2009.00801.x Duong, 2009, Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo, J. Exp. Med., 207, 173, 10.1084/jem.20091873 Doody, 1995, A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP, Science, 269, 242, 10.1126/science.7618087 Poe, 2000, CD22 forms a quaternary complex with SHIP, Grb2 and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux, J. Biol. Chem., 275, 17420, 10.1074/jbc.M001892200 Engel, 1993, The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils and monocytes, J. Immunol., 150, 4719, 10.4049/jimmunol.150.11.4719 Engel, 1995, Identification of the ligand binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand, J. Exp. Med., 181, 1581, 10.1084/jem.181.4.1581 Stamenkovic, 1990, The B cell antigen CD22 mediates monocyte and erythrocyte adhesion, Nature, 344, 74, 10.1038/345074a0 Kelm, 1994, Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily, Curr. Biol., 4, 965, 10.1016/S0960-9822(00)00220-7 Powell, 1993, Natural ligands of the B cell adhesion molecule CD22β carry N-linked oligosaccharides with α-2,6-linked sialic acids that are required for recognition, J. Biol. Chem., 268, 7019, 10.1016/S0021-9258(18)53140-9 Powell, 1994, The oligosaccharide binding specificities of CD22-β, a sialic acid-specific lectin of B-cells, J. Biol. Chem., 269, 10628, 10.1016/S0021-9258(17)34106-6 Munro, 1992, B lymphocyte surface antigen CD75 is not α-2,6-sialyltransferase but is a carbohydrate antigen modified by the enzyme, Cell, 68, 1003, 10.1016/0092-8674(92)90070-S Hanasaki, 1995, Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22: selective recognition of immunoglobulin M and haptoglobin, J. Biol. Chem., 270, 7543, 10.1074/jbc.270.13.7543 Stamenkovic, 1991, The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2,6 sialyltransferase, CD75, on B cells, Cell, 66, 1133, 10.1016/0092-8674(91)90036-X Pflugh, 2002, Ly-6 superfamily members Ly-6A/E, Ly-6C, and Ly-6I recognize two potential ligands expressed by B lymphocytes, J. Immunol., 169, 5130, 10.4049/jimmunol.169.9.5130 Leprince, 1993, CD22 associates with the human surface IgM-B cell antigen receptor complex, Proc. Natl. Acad. Sci. U.S.A., 90, 3236, 10.1073/pnas.90.8.3236 Han, 2005, Homomultimeric complexes of CD22 in B cells revealed by protein–glycan cross-linking, Nat. Chem. Biol., 1, 93, 10.1038/nchembio713 Pezzutto, 1987, Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp130/140, J. Immunol., 138, 98, 10.4049/jimmunol.138.1.98 Tooze, 1997, Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin, Immunity, 7, 59, 10.1016/S1074-7613(00)80510-5 Nitschke, 1997, CD22 is a negative regulator of B-cell receptor signaling, Curr. Biol., 7, 133, 10.1016/S0960-9822(06)00057-1 O’Keefe, 1996, Hyperresponsive B cells in CD22-deficient mice, Science, 274, 798, 10.1126/science.274.5288.798 Otipoby, 1996, CD22 regulates thymus-independent responses and the lifespan of B cells, Nature, 384, 634, 10.1038/384634a0 Sato, 1996, CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice, Immunity, 5, 551, 10.1016/S1074-7613(00)80270-8 Sato, 1997, CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling, Proc. Natl. Acad. Sci. U.S.A., 94, 13158, 10.1073/pnas.94.24.13158 Fujimoto, 1999, Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop, Immunity, 11, 191, 10.1016/S1074-7613(00)80094-1 Jin, 2002, Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling, J. Exp. Med., 195, 1199, 10.1084/jem.20011796 Kelm, 2002, The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound, J. Exp. Med., 195, 1207, 10.1084/jem.20011783 Razi, 1998, Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes, Proc. Natl. Acad. Sci. U.S.A., 95, 7469, 10.1073/pnas.95.13.7469 Collins, 2004, Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact, Proc. Natl. Acad. Sci. U.S.A., 101, 6104, 10.1073/pnas.0400851101 van der Merwe, 1996, Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22, J. Biol. Chem., 271, 9273, 10.1074/jbc.271.16.9273 Lanoue, 2002, Interaction of CD22 with a2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity?, Eur. J. Immunol., 32, 348, 10.1002/1521-4141(200202)32:2<348::AID-IMMU348>3.0.CO;2-5 Law, 1993, Organization of the murine Cd22 locus. Mapping to chromosome 7 and characterization of two alleles, J. Immunol., 151, 175, 10.4049/jimmunol.151.1.175 Mary, 2000, Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice, J. Immunol., 165, 2987, 10.4049/jimmunol.165.6.2987 Lajaunias, 1999, Polymorphisms in the Cd22 gene of inbred mouse strains, Immunogenetics, 49, 991, 10.1007/s002510050584 O’Keefe, 1999, Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies, J. Exp. Med., 189, 1307, 10.1084/jem.189.8.1307 Schultz, 1993, Mutations at the murine motheaten locus are within the hematopoietic cell protein–tyrosine phosphatase (Hcph) gene, Cell, 73, 1445, 10.1016/0092-8674(93)90369-2 Kozlowski, 1993, Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice, J. Exp. Med., 178, 2157, 10.1084/jem.178.6.2157 Cyster, 1995, Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection, Immunity, 2, 13, 10.1016/1074-7613(95)90075-6 Sato, 1996, CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity, J. Immunol., 157, 4371, 10.4049/jimmunol.157.10.4371 Asano, 2004, B lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse, Am. J. Pathol., 165, 641, 10.1016/S0002-9440(10)63328-7 Whitney, 2001, A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33, Eur. J. Biochem., 268, 6083, 10.1046/j.0014-2956.2001.02543.x Berland, 2002, Origins and functions of B-1 cells with notes on the role of CD5, Annu. Rev. Immunol., 20, 253, 10.1146/annurev.immunol.20.100301.064833 Jellusova, 2010, CD22 × Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity, J. Immunol., 184, 3618, 10.4049/jimmunol.0902711 Chen, 2009, CD24 and Siglec-10 selectively repress tissue damage-induced immune responses, Science, 323, 1722, 10.1126/science.1168988 Carlin, 2009, Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response, Blood, 113, 3333, 10.1182/blood-2008-11-187302 Haas, 2006, CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo, J. Immunol., 177, 3063, 10.4049/jimmunol.177.5.3063 O’Reilly, 2011, CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells, J. Immunol., 186, 1554, 10.4049/jimmunol.1003005 Poe, 2001, CD19, CD21 and CD22: multifaceted response regulators of B lymphocyte signal transduction, Int. Rev. Immunol., 20, 739, 10.3109/08830180109045588 Seite, 2010, IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes, Blood, 116, 1698, 10.1182/blood-2009-12-261461 Adachi, 2012, CD22 serves as a receptor for soluble IgM, Eur. J. Immunol., 42, 241, 10.1002/eji.201141899 Samardzic, 2002, Reduction of marginal zone B cells in CD22-deficient mice, Eur. J. Immunol., 32, 561, 10.1002/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H